SHC_PHARMACY_LIMITED - Accounts

Company Registration No. SC130669 (Scotland)
SHC PHARMACY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
SHC PHARMACY LIMITED
COMPANY INFORMATION
Directors
Mr C Shanks
Ms J Edgely
Secretary
Mr C Shanks
Company number
SC130669
Registered office
Sighthill Health Centre
Calder Road
Edinburgh
EH11 4AU
Accountants
Geoghegans Accountancy Limited
Chartered Accountants
6 St Colme Street
Edinburgh
EH3 6AD
SHC PHARMACY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
SHC PHARMACY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2018
31 March 2018
- 1 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
3
8,926
1,092
Current assets
Stocks
76,744
73,997
Debtors
4
219,805
196,825
Cash at bank and in hand
162,097
294,239
458,646
565,061
Creditors: amounts falling due within one year
5
(298,600)
(305,238)
Net current assets
160,046
259,823
Total assets less current liabilities
168,972
260,915
Provisions for liabilities
(1,518)
(186)
Net assets
167,454
260,729
Capital and reserves
Called up share capital
6
60
60
Profit and loss reserves
167,394
260,669
Total equity
167,454
260,729

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

SHC PHARMACY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2018
31 March 2018
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 22 August 2018 and are signed on its behalf by:
Ms J Edgely
Director
Company Registration No. SC130669
SHC PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
- 3 -
1
Accounting policies
Company information

SHC Pharmacy Limited is a private company limited by shares incorporated in Scotland. The registered office is Sighthill Health Centre, Calder Road, Edinburgh, EH11 4AU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents net invoiced sales of goods and services, excluding value added tax.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% straight line
Fixtures, fittings & equipment
10% straight line
Computer equipment
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

The carrying value of tangible fixed assets are reviewed for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable.

1.5
Stocks

Stocks are stated at the lower of cost and net realisable value after making due allowances for obsolete and slow moving items. Cost is determined on a first-in, first-out basis. Net realisable value is based on estimated selling price, less any further costs of realisation.

1.6
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

SHC PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors

Debtors with no stated interest rate or receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Creditors

Creditors with no stated interest rate and payable within one year are recorded at transaction price.

 

All interest bearing loans and borrowings which are basic financial instruments are initially recorded at the present value of cash payable. After initial recognition they are measured at amortised cost.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

SHC PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 5 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the profit and loss account in the period to which they relate.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 11 (2017 - 10).

3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2017
23,807
Additions
8,314
At 31 March 2018
32,121
Depreciation and impairment
At 1 April 2017
22,716
Depreciation charged in the year
479
At 31 March 2018
23,195
Carrying amount
At 31 March 2018
8,926
At 31 March 2017
1,092
SHC PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 6 -
4
Debtors
2018
2017
Amounts falling due within one year:
£
£
Trade debtors
167,615
153,803
Other debtors
52,190
43,022
219,805
196,825
5
Creditors: amounts falling due within one year
2018
2017
£
£
Trade creditors
201,182
202,980
Corporation tax, other taxation and social security
53,671
68,229
Other creditors
43,747
34,029
298,600
305,238
6
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
60 ordinary shares of £1 each
60
60
60
60
7
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2018
2017
£
£
618,750
663,750
8
Related party transactions

The directors are of the opinion that all related party transactions are conducted under normal market conditions and on an arm's length basis and therefore do not need to be disclosed under FRS 102 section 1A appendix C.

2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.220No description of principal activity22 August 2018Mr C ShanksMs J EdgelyMr C ShanksSC1306692017-04-012018-03-31SC130669bus:Director12017-04-012018-03-31SC130669bus:Director22017-04-012018-03-31SC130669bus:CompanySecretary12017-04-012018-03-31SC130669bus:CompanySecretaryDirector12017-04-012018-03-31SC130669bus:RegisteredOffice2017-04-012018-03-31SC1306692018-03-31SC1306692017-03-31SC130669core:OtherPropertyPlantEquipment2018-03-31SC130669core:OtherPropertyPlantEquipment2017-03-31SC130669core:CurrentFinancialInstruments2018-03-31SC130669core:CurrentFinancialInstruments2017-03-31SC130669core:ShareCapital2018-03-31SC130669core:ShareCapital2017-03-31SC130669core:RetainedEarningsAccumulatedLosses2018-03-31SC130669core:RetainedEarningsAccumulatedLosses2017-03-31SC130669core:ShareCapitalOrdinaryShares2018-03-31SC130669core:ShareCapitalOrdinaryShares2017-03-31SC130669core:PlantMachinery2017-04-012018-03-31SC130669core:FurnitureFittings2017-04-012018-03-31SC130669core:ComputerEquipment2017-04-012018-03-31SC130669core:OtherPropertyPlantEquipment2017-03-31SC130669core:OtherPropertyPlantEquipment2017-04-012018-03-31SC130669bus:OrdinaryShareClass12017-04-012018-03-31SC130669bus:OrdinaryShareClass12018-03-31SC130669bus:PrivateLimitedCompanyLtd2017-04-012018-03-31SC130669bus:FRS1022017-04-012018-03-31SC130669bus:AuditExemptWithAccountantsReport2017-04-012018-03-31SC130669bus:SmallCompaniesRegimeForAccounts2017-04-012018-03-31SC130669bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP